FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and concerns a formulation of a soft gelatine capsule containing inecalcitol, at least one long-chain triglyceride (LCT) and pharmaceutically acceptable excipients.
EFFECT: invention provides a therapeutic formulation having the improved absorption profile.
11 cl, 4 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
NEW FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D | 2011 |
|
RU2575819C2 |
NEW THERAPEUTIC METHODS FOR USING INECALCITOL | 2010 |
|
RU2571490C2 |
ADVANCED DRUG DELIVERY SYSTEM | 2004 |
|
RU2353350C2 |
STABILISED LIPID PREPARATIVE FORM OF APOPTOSIS PROMOTER | 2010 |
|
RU2530642C2 |
PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
COMPOSITIONS CONTAINING UROLITINS | 2016 |
|
RU2754761C2 |
ABT-263 CAPSULE | 2010 |
|
RU2550956C2 |
PHARMACEUTICAL COMPOSITION BASED ON INDOMETHACIN MENTHYL ESTER IN FORM OF SOLID SELF-EMULSIFYING SYSTEM | 2023 |
|
RU2823982C1 |
CAPSULES WITH SOLUBLE OESTRADIOL FOR INTRAVAGINAL INTRODUCTION | 2013 |
|
RU2740059C2 |
SEMIFIRM SYSTEMS CONTAINING DERIVATIVES OF AZETIDINUM | 2004 |
|
RU2343915C2 |
Authors
Dates
2016-02-20—Published
2011-07-13—Filed